HEALTH● LOWSep 15 · Sep 15, 2026, 9:46 AM
ORIC (ORIC) Doubles Down On Prostate Cancer With Phase 3 Launch
Yahoo Finance · global
ORIC is advancing its efforts in prostate cancer treatment by launching a Phase 3 study. This indicates progress in pharmaceutical development aimed at addressing a significant health issue.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH51m agoAlan Alda, 90-year-old actor, talks about his life with Parkinson's and a neuropsychiatrist confirms his most powerful tool against the diagnosisClarínHEALTH57m ago43 women rescued in illegal human egg harvesting racket in HyderabadThe HinduHEALTHBREAKING1h agoEbola deaths top 5,000 as fear of continent-wide spread mountsAfricanews [en]HEALTH1h agoAllergic reactions after sex should be listed as an antibiotic risk, experts sayNew Scientist